Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms. - Wikidata - awgldk - TriplyDB

Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.

Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.

http://www.wikidata.org/entity/Q37093626

about

Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease Recent advances in understanding bile duct remodeling and fibrosis

P2860

Q38738028-A474F84D-7A66-4308-82A9-5ECB2FB83C65 Q57109378-550B3F44-7983-4464-AA02-396DAB58E995 Q57113746-AECF8AF9-C890-4D05-B661-7800A120A66D

P2860

Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.

http://www.wikidata.org/entity/Q37093626

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuropeptide Y inhibits biliar ...... rine and autocrine mechanisms.

@en

Neuropeptide Y inhibits biliar ...... rine and autocrine mechanisms.

@nl

type

label

Neuropeptide Y inhibits biliar ...... rine and autocrine mechanisms.

@en

Neuropeptide Y inhibits biliar ...... rine and autocrine mechanisms.

@nl

prefLabel

Neuropeptide Y inhibits biliar ...... rine and autocrine mechanisms.

@en

Neuropeptide Y inhibits biliar ...... rine and autocrine mechanisms.

@nl

P1433

Q37093626-01F3F9BE-6B15-4828-B709-28E09586BF02

P1476

Q37093626-85F40555-8EB1-441E-8B4B-E0E407B1FCB3

P2093

Q37093626-06AF19A8-C5F1-4F85-8ECF-6EDE900D4AD8

Q37093626-2164711E-7D2C-4DC4-B155-927830019C24

Q37093626-222973E5-F884-4545-B482-F0F6076BE79F

Q37093626-3099A21A-F10A-44B7-974B-7D5B77D55534

Q37093626-3CD9CC48-C6EC-42D8-9327-6EA4E11D08BC

Q37093626-4F6EA580-2C51-4835-A161-B06BEE85188A

Q37093626-8B970EC5-6B00-41D7-A1F1-BE26ED74C6CF

Q37093626-A38729A3-0A87-4E87-ADDC-16EFCC33BB07

Q37093626-A9B1BD87-EA7B-493E-B60B-E6FB697F5240

Q37093626-AB3F0E2F-0C55-4B9A-B5EA-0038B27B18E6

P2860

Q37093626-0782098B-2C65-4C46-B6CE-FB96E214C8D2

Q37093626-08068A5B-63DF-42AE-BAD3-A6B918387F6B

Q37093626-1D72283B-AC1D-450F-B4CB-417A76E4D39D

Q37093626-1DD8EAC9-0145-4AC7-BAC0-935A64032866

Q37093626-2B1183FD-B72C-4448-9DA2-FB6DB7C19DA6

Q37093626-3D8751FB-41C8-4524-85B2-D8BBF53A13A2

Q37093626-4243FFEC-66E1-49B4-A42D-EA2E725C203A

Q37093626-5E3CC1AA-03F0-4ED9-A296-45CDF4321684

Q37093626-62139D15-2F10-4D9C-B677-10176402ED7A

Q37093626-710C0D0A-5D54-42A7-9697-AB6DB6B792BA

P304

Q37093626-6B58E473-D426-4659-AFAF-703CEF4BF665

P31

Q37093626-EBA2F46F-B011-42B4-80F0-91F2CE823017

P356

Q37093626-DF9DA82A-E840-4615-8BE4-D8B1FCFE3F0E

P433

Q37093626-2DD0ECF5-FAF4-46C4-93FF-3D2DBA125D99

P478

Q37093626-A0231CC8-FD38-4872-B7BC-675D50A27232

P50

Q37093626-24D6A3FE-C54C-49F4-A5FB-B6B5E4D72647

Q37093626-D92514DF-4B0F-418B-97A4-41D0825EE60E

Q37093626-EF636730-D568-431F-8359-A0B5D4EAE502

P577

Q37093626-1B4B6C0C-401D-4125-85A7-317B224A3729

P5875

Q37093626-F9C51483-B346-4394-89FA-3D8D64982AA4

P698

Q37093626-4B47F16E-C3D3-419D-AC33-FF6C7147BBE9

P932

Q37093626-64C4C01D-B155-465D-97BE-0114122657E5

P356

AJPGI.00140.2013

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Neuropeptide Y inhibits biliar ...... crine and autocrine mechanisms

@en

P2093

Dinorah Leyva-Illades

http://www.w3.org/2001/XMLSchema#string

Eugenio Gaudio

http://www.w3.org/2001/XMLSchema#string

Fanyin Meng

http://www.w3.org/2001/XMLSchema#string

Gabriel Frampton

http://www.w3.org/2001/XMLSchema#string

Gianfranco Alpini

http://www.w3.org/2001/XMLSchema#string

Hae Yong Pae

http://www.w3.org/2001/XMLSchema#string

Heather Francis

http://www.w3.org/2001/XMLSchema#string

Julie Venter

http://www.w3.org/2001/XMLSchema#string

Kelly McDaniel

http://www.w3.org/2001/XMLSchema#string

Matthew Quinn

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Circulating levels of neuropeptides (CGRP, VIP, NPY) in patients with fulminant hepatic failure

Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation

NPY family of hormones: clinical relevance and potential use in gastrointestinal disease

BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist

Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism

Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

Modulatory Actions of Neuropeptide Y on Prostate Cancer Growth: Role of MAP Kinase/ERK 1/2 Activatio

Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats.

Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.

P304

G250-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00140.2013

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P50

Romina Mancinelli

Antonio Franchitto

P577

2013-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236908684

http://www.w3.org/2001/XMLSchema#string

P698

23703654

http://www.w3.org/2001/XMLSchema#string

P932

3742859

http://www.w3.org/2001/XMLSchema#string